Ticagrelor shift from PLATO to PEGASUS: Vanished mortality benefit, excess cancer deaths, massive discontinuations, and overshooting target events
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference19 articles.
1. Ticagrelor for acute coronary syndromes;Bansilal;Expert. Rev. Cardiovasc. Ther.,2013
2. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N. Engl. J. Med.,2009
3. Paradoxical excess mortality in the PLATO trial should be independently verified;Serebruany;Thromb. Haemost.,2011
4. Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrel;DiNicolantonio;Int. J. Cardiol.,2013
5. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI;Levine;Nat. Rev. Cardiol.,2014
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging roles of platelets in cancer biology and their potential as therapeutic targets;Frontiers in Oncology;2022-07-22
2. Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues;Frontiers in Oncology;2021-07-12
3. Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial;American Journal of Therapeutics;2020-10-23
4. P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation;International Journal of Molecular Sciences;2020-02-19
5. De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention;Chinese Medical Journal;2019-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3